SCHEMBL20236404

SCHEMBL20236404

COC(=O)c1ccc(CNc2ccc(C)c(Cl)c2)c(F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.52
ALDH1A1 P00352 5/20 0.52
AGTR1 P30556 3/20 0.49
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
CASP3 P42574 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
GAA P10253 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CYP2C19 P33261 4/20 0.46
CYP1A2 P05177 3/20 0.46
HKDC1 Q2TB90 1/20 0.45
HPGD P15428 1/20 0.45
CYP3A4 P08684 3/20 0.45
CYP2C9 P11712 3/20 0.45
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PLA2G1B P04054 1/20 0.44
CYP2D6 P10635 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22236350 0.98 MAPT (0.50) MAPTALDH1A1AGTR1MEN1KMT2A
SCHEMBL20236457 0.90 MAPT (0.60) MAPTALDH1A1MEN1KMT2ACASP3
SCHEMBL20236155 0.88 ALDH1A1 (0.52) MAPTALDH1A1AGTR1MEN1KMT2A
SCHEMBL20236349 0.85 HKDC1 (0.52) MAPTALDH1A1MEN1KMT2ACASP3
SCHEMBL17618059 0.84 HKDC1 (0.53) MAPTALDH1A1SMN1; SMN2HKDC1HPGD
SCHEMBL20236937 0.82 EGFR (0.52) MAPTALDH1A1MEN1KMT2ACASP3
SCHEMBL17618052 0.81 EGFR (0.53) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL20236558 0.81 HKDC1 (0.47) MAPTALDH1A1MEN1KMT2ACASP3
SCHEMBL18423980 0.80 HIF1A (0.59) MAPTALDH1A1AGTR1MEN1KMT2A
SCHEMBL30024522 0.80 HIF1A (0.59) MAPTALDH1A1AGTR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331864-B1 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2021-11-03 EP disclosed
CN-108137518-B 1,3, 4-oxadiazole derivative compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same 株式会社钟根堂 2021-08-31 CN disclosed
US-10717716-B2 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2020-07-21 US disclosed
US-10717716-B2 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2020-07-21 US disclosed
EP-3331864-A2 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2018-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10717716-B2 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same HDAC1, HDAC5, HDAC2 MAPT 1679/4885ALDH1A1 152/4885AGTR1 2327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.